Life Tech Partners with DaAn to Bring Sanger-Based Dx to Chinese Market | GenomeWeb

Life Technologies is partnering with DaAn Gene, a Chinese molecular in vitro diagnostics company, to form Life Technologies DaAn Diagnostics.

Based in Guangzhou, the company will develop and commercialize a suite of assays using Life Tech's 3500Dx capillary electrophoresis instrument and the Big Dye Cycle Sequencing technologies. Life Tech's 3500Dx was approved by the China State Food and Drug Administration for IVD use last October.

The new company will aim develop IVD assays for oncology, infectious diseases, and genetic diseases.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.